Number of Shares
2.15 Mil
Current Holdings Value*
$12.16 Mil
% of Portfolio
8.11%
Total Estimate Gain
$1.34 Mil
% of Total Estimate Gain
10.22%

ACORN CAPITAL ADVISORS, LLC's Candel Therapeutics Inc Holding Summary

As of 2025-03-31, ACORN CAPITAL ADVISORS, LLC held 2.15 Mil shares of Candel Therapeutics Inc(CADL), totaling $12.16 Mil. This investment constitutes 8.11% of their stock portfolio, and ACORN CAPITAL ADVISORS, LLC now holds 4.37% of the outstanding Candel Therapeutics Inc(CADL) stock.

The initial trade took place in 2024Q4. And since then ACORN CAPITAL ADVISORS, LLC has made 1 purchases of CADL, at an average price of $6.12, for a total of 2.15 Mil shares. Based on historical transaction data and CADL's current price of $6.74, ACORN CAPITAL ADVISORS, LLC's estimated gain on his CADL holdings is $1.34 Mil, reflecting a 10.22% gain to date.

ACORN CAPITAL ADVISORS, LLC CADL ($6.74) Holding Chart

ACORN CAPITAL ADVISORS, LLC CADL ($6.74) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1